期刊文献+

脂肪间充质干细胞治疗糖尿病及其慢性并发症的研究进展

Advances of adipose-derived mesenchymal stem cells in the treatment of diabetes mellitus and its chronic complications
原文传递
导出
摘要 糖尿病是常见的慢性病之一,持续的高血糖状态可以引起大血管系统和微血管系统的多种慢性并发症,是造成糖尿病患者死亡的主要原因。脂肪间充质干细胞(ADSCs)具有取材方便、分离简单和易于培养等特点,在治疗糖尿病及其慢性并发症方面表现出广阔应用潜力,现将近年来ADSCs在糖尿病及其慢性并发症治疗中取得的研究进展进行综述。 Diabetes mellitus is one of the most common and severe chronic diseases worldwide.Continuous hyperglycemia leads to various of chronic complications in the macrovascular and microvascular systems,which is the main cause of death in patients with diabetes.Adipose-derived mesenchymal stem cells(ADSCs),which are easy to obtain,simple to isolate and easy to culture,have shown great potential in treating diabetes mellitus and its chronic complications.This paper reviews the research progress of ADSCs in treating diabetes mellitus and its chronic complications in recent years.
作者 郭庆 李冠琳 刘慧 魏炜 于洋 张纯 Guo Qing;Li Guanlin;Liu Hui;Wei Wei;Yu Yang;Zhang Chun(Clinical Stem Cell Research Center,Peking University Third Hospital,Beijing 100191,China)
出处 《中华细胞与干细胞杂志(电子版)》 2023年第1期58-62,共5页 Chinese Journal of Cell and Stem Cell(Electronic Edition)
基金 国家自然科学基金项目(82101780) 北京大学第三医院临床重点项目(BYSYZD2021031)。
关键词 脂肪间充质干细胞 糖尿病 胰岛Β细胞 胰岛素抵抗 Adipose-derived mesenchymalstem cells Diabetes mellitus Pancreatic β-cell Insulin resistance
  • 相关文献

参考文献4

二级参考文献21

  • 1Nitzan O, Elias M, Chazan B, et al. Urinary tract infections in pa- tients with type 2 diabetes mellitus : review of prevalence, diagnosis, and management [J]. Diabetes Metab Syndr Obes, 2015, 8: 129-136. 被引量:1
  • 2Kong D, Zhuang X, Wang D, et al. Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus [ J ]. Clin Lab, 2014,60 (12) : 1969-1976. 被引量:1
  • 3Lei L, Zhang X, Mao Y, et al. Statin therapy and bone marrow CD34^+ cell frequency in type 2 diabetes mellitus: a cross-sectional study [J]. Int J Cardiol, 2014,175(1 ) :214-216. 被引量:1
  • 4Tong Q, Duan L, Xu Z, et al. Improved insulin secretion following in- trapancreatie UCB transplantation in patients with T2DM [J]. J Clin Endocrinol Metab, 2013.98 (9) : E 1501 - 1504. 被引量:1
  • 5Bhansali A, Upreti V, Walia R, et al. Efficacy and safety of autolo- gous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM:a 15 months follow-up study [J]. Indian J Endocrinol Metab, 2014,18 (6) : 838-845. 被引量:1
  • 6Bhansali A, Asokumar P, Walia R, et al. Efficacy and safety of autol- ogous bone marrow- derived stem cell transplantation in patients with type 2 diabetes mellitus : a randomized placebo-controlled study [J]. Cell Transplant, 2014,23 (9) : 1075-1085. 被引量:1
  • 7Bhansali A, Upreti V, Khandelwal N, et al. Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes rnellitus[J ]. Stem Ceils Dev, 2009,18(10) : 1407-1416. 被引量:1
  • 8Liu X, Zheng P, Wang X, et al. A preliminary evaluation of efficacy and safety of Wharton' s jelly mesenchymal stem cell transplanta- tion in patients with type 2 diabetes mellitus [J]. Stem Cell Res Ther,2014,5(2) :57. 被引量:1
  • 9Jiang R, Han Z, Zhuo G, et al. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study [J ]. Front Med,2011,5(1) :94-100. 被引量:1
  • 10Tzouvelekis A, Paspaliaris V, Koliakos G, et al. A prospective, non- randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular frac- tion in idiopathic pulmonary fibrosis [J]. J Transl Med, 2013, 11: 171. 被引量:1

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部